ACP Issues Clinical Guideline for Statin Use in Persons With HIV
THURSDAY, May 29, 2025 -- In a clinical guideline issued by the American College of Physicians and published online May 27 in the Annals of Internal Medicine, recommendations are presented for the use of statins among persons with HIV (PWH).
Craig Beavers, Pharm.D., from the University of Kentucky College of Pharmacy in Lexington, and colleagues developed statin therapy recommendations for PWH. A writing group of 10 members was convened; data were reviewed from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), other studies, and current guidelines.
The U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel) issued strong recommendations for initiation of statin therapy among PWH with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk score of 5 percent or higher, who derived the greatest benefit from statins in REPRIEVE. The panel favored statins for patients with a 10-year ASCVD risk score below 5 percent, but recommended patient-clinician risk discussions that accounted for additional HIV-related risk factors that could potentially increase ASCVD risk.
"There remain important clinical questions in the management of CVD risk among PWH, including further improvements in risk stratification, as well as additional ASCVD prevention strategies focused on reducing residual risk associated with inflammation," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Three Cardiometabolic Risk Factors ID'd as Having the Highest Risk for Mortality in MASLD
TUESDAY, Sept. 23, 2025 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the cardiometabolic risk factors (CMRFs) of high blood pressure...
HIV Infections Projected to Rise With Cessation of Ryan White Services
MONDAY, Sept. 15, 2025 -- Cessation of Ryan White services, which provide care for more than half of people with HIV in the United States, could yield an increase in HIV...
More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis
THURSDAY, July 24, 2025 -- Although the rate of perinatal HIV infection is low, more than 50 percent of HIV infections in infants before age 1 year occurred in those who did not...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.